In this study, sustained expression of Tnip1 using an AAV vector attenuated diabetes-induced vascular dysfunction in vivo, demonstrating its therapeutic potential for the management of diabetes-associated vascular complications. Here, TNIP1 is linked to diabetes mellitus.